SPDR S&P Biotech (XBI) 251.38 $XBI
Cramer -- Gilead Has a ‘Fabulous’ Quarter, Tons of Merger Opportunities
at The Street - Wed Jul 29, 9:35AM CDT
Gilead Sciences not only beat earnings estimates but it can make a massive acquisition should it want to do so, Cramer says.
GILD: 116.57 (+3.50), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 1.41% Sell Off
Comtex SmarTrend(R) - Mon Jul 27, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $247.78 to a high of $253.92. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $253.77 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground
at The Street - Mon Jul 27, 10:38AM CDT
Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors.
BIIB: 310.61 (-9.32), GRUB: 32.33 (-0.92), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), REGN: 540.29 (-12.16), CELG: 132.61 (-2.81)
XBI, ANAC, EXEL, RDUS: ETF Inflow Alert
ETFChannel.com - Thu Jul 23, 10:16AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $133.7 million dollar inflow -- that's a 4.4% increase...
XBI: 251.38 (-7.56)
SmarTrend Watching for Potential Rebound in Shares of SPDR S&P Biotech ETF After 1.69% Loss
Comtex SmarTrend(R) - Tue Jul 21, 3:58PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $262.56 to a high of $270.37. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $265.05 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
SPDR S&P Biotech ETF Shares Up 17.2% Since SmarTrend's Buy Recommendation (XBI)
Comtex SmarTrend(R) - Tue Jul 21, 10:52AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 18th, 2015 at $228.31. In approximately 2 months, SPDR S&P Biotech ETF has returned 17.21% as of today's recent price of $267.59.
XBI: 251.38 (-7.56)
'Fast Money' Recap: Netflix, Google, Other Tech Earnings to Watch
at The Street - Wed Jul 15, 4:00AM CDT
The trading panel discusses what to buy and what to avoid.
FB: 96.11 (+0.82), FBT: 124.02 (-2.58), XBI: 251.38 (-7.56), AMGN: 169.62 (-3.12), IBB: 375.89 (-6.95), INTC: 29.08 (+0.12), CELG: 132.61 (-2.81), NFLX: 106.71 (-0.19), SPY: 210.29 (+0.96), GILD: 116.57 (+3.50), KITE: 70.34 (-1.57), RCPT: 227.93 (+0.77), JUNO: 47.87 (-0.75), TWTR: 31.52 (-5.02), AAPL: 122.82 (-0.56), Z: 78.92 (-1.27)
Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015 - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 8:30AM CDT
Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015
XOP: 39.74 (+0.89), XT: 25.66 (+0.12), UBIO: 18.50 (-1.06), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), LABU: 45.77 (-4.27), ZBIO: 20.25 (+0.94), CHAD: 46.73 (-1.09), YLCO: 13.33 (+0.04), LABD: 30.22 (+2.27), DRIP: 68.66 (-5.59), ASHR: 41.06 (+1.12), GUSH: 19.30 (+1.13)
After Yesterday's Rally of 2.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 13, 4:29PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $255.00 to a high of $260.10. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $252.82 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 251.38 (-7.56)
It's Time for Investors to Focus on Individual Stocks, Not Macro Events
at The Street - Mon Jul 13, 1:42PM CDT
The 'Fast Money Halftime' trading panel says that in this weak macro market, momentum stocks, individual companies and specific sectors should be the theme for investors, not broad-based index funds.
FIT: 44.57 (-0.90), GREK: 9.64 (-0.02), XBI: 251.38 (-7.56), C: 59.03 (+0.66), IBB: 375.89 (-6.95), BAC: 18.16 (+0.28), TLT: 120.61 (-0.54), MS: 39.29 (+0.04), NFLX: 106.71 (-0.19), SPY: 210.29 (+0.96), GS: 207.54 (+1.30), JPM: 68.91 (+0.86), QQQ: 111.34 (+0.21), DIA: 177.11 (+1.00), IWM: 121.78 (+0.18), XLF: 25.23 (+0.19)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 3.69% Sell Off
Comtex SmarTrend(R) - Wed Jul 08, 4:12PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $241.12 to a high of $249.05. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $243.30 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Noteworthy ETF Inflows: XBI, RDUS, KYTH, ZIOP
ETFChannel.com - Mon Jul 06, 10:02AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $98.7 million dollar inflow -- that's a 3.8% increase...
XBI: 251.38 (-7.56)
Top Performing ETF Areas Of 1H
Zacks Funds - Seeking Alpha - Thu Jul 02, 4:55AM CDT
Despite a long list of concerns, 2015 has so far been a great year for some corners of the investment universe. Though a harsh winter, a soaring greenback and the Fed rate hike worries took the shine away from the U.S. market in Q1, we saw strength...
BBP: 35.34 (-0.97), DXJF: 30.10 (+0.17), CNXT: 45.83 (+2.14), DXJH: 34.24 (+0.31), XBI: 251.38 (-7.56), ECNS: 49.41 (+0.95), QQQC: 22.61 (unch), HEDJ: 63.68 (+0.28), SBIO: 37.39 (-1.11), BBC: 35.75 (-0.92), RBL: 16.48 (+0.54), DBEZ: 28.27 (+0.06), RSX: 17.30 (+0.51), ERUS: 13.29 (+0.42), HEZU: 28.25 (+0.12), ASHS: 50.90 (+2.60)
Deforestation Impacting Pharmaceutical Industry
Global Risk Insights - at Seeking Alpha - Tue Jun 30, 3:07PM CDT
Global rainforests hold unknown treasures for fighting and curing multiple diseases. But whilst the complete destruction of the world’s remaining rainforests looms on the horizon, pharmaceutical companies are only slowly beginning to tap this...
AZN: 32.93 (+0.12), PFE: 35.69 (+0.34), MRK: 58.61 (+1.09), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), GSK: 42.76 (+1.05), BMY: 64.56 (-0.10), SNY: 53.84 (+0.03), NVS: 103.76 (+0.97)
The Pharma Pipeline: Exploring An Underestimated Investment Theme
Manning & Napier - at Seeking Alpha - Tue Jun 30, 2:43PM CDT
Worldwide equity markets have had an impressive showing since emerging from the Great Recession. The run-up in prices has coincided with equities becoming broadly more expensive. Some regions offer more attractive opportunities than others from a...
XBI: 251.38 (-7.56), IBB: 375.89 (-6.95)
40% Return In ~4 Months With Our IP Selected Healthcare Companies Since SA Publication
Innovalpha - Seeking Alpha - Tue Jun 30, 10:48AM CDT
We wanted to know how the " 17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes " performed since SA publication on February 10th 2015, namely JAZZ, SAGE, TNXP, SGYP, ASPX, XNPT, INSM, RNN, NVDQ, ZSPH, ACUR, ICPT, RDHL,...
SGYP: 8.09 (-0.15), INSM: 26.57 (-0.45), RNN: 0.53 (unch), RDHL: 14.73 (-0.68), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), ACUR: 0.81 (+0.07), CORI: 13.93 (+0.13), SPNC: 16.96 (+1.31), SAGE: 68.01 (-4.82), TNXP: 8.05 (-0.03), EBIO: 2.79 (+0.03), HAE: 39.14 (+0.07), JAZZ: 188.80 (-4.22), ICPT: 268.00 (-6.94)
SPDR S&P Biotech ETF Falls 3.34% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jun 29, 5:30PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $241.30 to a high of $249.80. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $245.92 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Biotech Weekly: Top Value Biotech Picks Starting Q3 2015
Daniel Ward - at Seeking Alpha - Mon Jun 29, 10:17AM CDT
OXGN: 1.39 (+0.04), ROKA: 3.09 (+0.02), ECYT: 5.06 (-0.14), BOTA: 2.40 (+0.09), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), CLDN: 1.25 (unch), NVET: 4.05 (-0.07), BLPH: 3.83 (+0.11), MEIP: 1.64 (+0.07)
5 Stocks Leading XBI Biotech ETF Higher
Zacks Funds - Seeking Alpha - Fri Jun 26, 5:09AM CDT
The biotech corner of the health care space is having a stellar run like last year and still remains a favorite investment destination for investors. This is primarily thanks to strong earnings growth, merger & acquisition frenzy, promising drug...
HRTX: 32.70 (-1.19), XBI: 251.38 (-7.56), RTRX: 31.58 (-1.45), EGRX: 92.27 (-0.57), PRTA: 66.11 (-2.59), EXEL: 5.62 (+0.21)
Cramer -- Gilead Has a ‘Fabulous’ Quarter, Tons of Merger Opportunities
at The Street - Wed Jul 29, 9:35AM CDT
Gilead Sciences not only beat earnings estimates but it can make a massive acquisition should it want to do so, Cramer says.
GILD: 116.57 (+3.50), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 1.41% Sell Off
Comtex SmarTrend(R) - Mon Jul 27, 4:07PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $247.78 to a high of $253.92. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $253.77 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground
at The Street - Mon Jul 27, 10:38AM CDT
Jim Cramer is not hungry for GrubHub and says Biogen is turning into a battle royale for biotech investors.
BIIB: 310.61 (-9.32), GRUB: 32.33 (-0.92), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), REGN: 540.29 (-12.16), CELG: 132.61 (-2.81)
XBI, ANAC, EXEL, RDUS: ETF Inflow Alert
ETFChannel.com - Thu Jul 23, 10:16AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $133.7 million dollar inflow -- that's a 4.4% increase...
XBI: 251.38 (-7.56)
SmarTrend Watching for Potential Rebound in Shares of SPDR S&P Biotech ETF After 1.69% Loss
Comtex SmarTrend(R) - Tue Jul 21, 3:58PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $262.56 to a high of $270.37. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $265.05 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
SPDR S&P Biotech ETF Shares Up 17.2% Since SmarTrend's Buy Recommendation (XBI)
Comtex SmarTrend(R) - Tue Jul 21, 10:52AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 18th, 2015 at $228.31. In approximately 2 months, SPDR S&P Biotech ETF has returned 17.21% as of today's recent price of $267.59.
XBI: 251.38 (-7.56)
'Fast Money' Recap: Netflix, Google, Other Tech Earnings to Watch
at The Street - Wed Jul 15, 4:00AM CDT
The trading panel discusses what to buy and what to avoid.
FB: 96.11 (+0.82), FBT: 124.02 (-2.58), XBI: 251.38 (-7.56), AMGN: 169.62 (-3.12), IBB: 375.89 (-6.95), INTC: 29.08 (+0.12), CELG: 132.61 (-2.81), NFLX: 106.71 (-0.19), SPY: 210.29 (+0.96), GILD: 116.57 (+3.50), KITE: 70.34 (-1.57), RCPT: 227.93 (+0.77), JUNO: 47.87 (-0.75), TWTR: 31.52 (-5.02), AAPL: 122.82 (-0.56), Z: 78.92 (-1.27)
Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015 - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Jul 14, 8:30AM CDT
Zacks Investment Ideas feature highlights: The Best, Most Interesting ETFs to Launch in the First Half 2015
XOP: 39.74 (+0.89), XT: 25.66 (+0.12), UBIO: 18.50 (-1.06), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), LABU: 45.77 (-4.27), ZBIO: 20.25 (+0.94), CHAD: 46.73 (-1.09), YLCO: 13.33 (+0.04), LABD: 30.22 (+2.27), DRIP: 68.66 (-5.59), ASHR: 41.06 (+1.12), GUSH: 19.30 (+1.13)
After Yesterday's Rally of 2.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 13, 4:29PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $255.00 to a high of $260.10. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $252.82 on volume of 1.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
XBI: 251.38 (-7.56)
It's Time for Investors to Focus on Individual Stocks, Not Macro Events
at The Street - Mon Jul 13, 1:42PM CDT
The 'Fast Money Halftime' trading panel says that in this weak macro market, momentum stocks, individual companies and specific sectors should be the theme for investors, not broad-based index funds.
FIT: 44.57 (-0.90), GREK: 9.64 (-0.02), XBI: 251.38 (-7.56), C: 59.03 (+0.66), IBB: 375.89 (-6.95), BAC: 18.16 (+0.28), TLT: 120.61 (-0.54), MS: 39.29 (+0.04), NFLX: 106.71 (-0.19), SPY: 210.29 (+0.96), GS: 207.54 (+1.30), JPM: 68.91 (+0.86), QQQ: 111.34 (+0.21), DIA: 177.11 (+1.00), IWM: 121.78 (+0.18), XLF: 25.23 (+0.19)
Look for Shares of SPDR S&P Biotech ETF to Potentially Rebound after Yesterday's 3.69% Sell Off
Comtex SmarTrend(R) - Wed Jul 08, 4:12PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $241.12 to a high of $249.05. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $243.30 on volume of 2.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Noteworthy ETF Inflows: XBI, RDUS, KYTH, ZIOP
ETFChannel.com - Mon Jul 06, 10:02AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF where we have detected an approximate $98.7 million dollar inflow -- that's a 3.8% increase...
XBI: 251.38 (-7.56)
Top Performing ETF Areas Of 1H
Zacks Funds - Seeking Alpha - Thu Jul 02, 4:55AM CDT
Despite a long list of concerns, 2015 has so far been a great year for some corners of the investment universe. Though a harsh winter, a soaring greenback and the Fed rate hike worries took the shine away from the U.S. market in Q1, we saw strength...
BBP: 35.34 (-0.97), DXJF: 30.10 (+0.17), CNXT: 45.83 (+2.14), DXJH: 34.24 (+0.31), XBI: 251.38 (-7.56), ECNS: 49.41 (+0.95), QQQC: 22.61 (unch), HEDJ: 63.68 (+0.28), SBIO: 37.39 (-1.11), BBC: 35.75 (-0.92), RBL: 16.48 (+0.54), DBEZ: 28.27 (+0.06), RSX: 17.30 (+0.51), ERUS: 13.29 (+0.42), HEZU: 28.25 (+0.12), ASHS: 50.90 (+2.60)
Deforestation Impacting Pharmaceutical Industry
Global Risk Insights - at Seeking Alpha - Tue Jun 30, 3:07PM CDT
Global rainforests hold unknown treasures for fighting and curing multiple diseases. But whilst the complete destruction of the world’s remaining rainforests looms on the horizon, pharmaceutical companies are only slowly beginning to tap this...
AZN: 32.93 (+0.12), PFE: 35.69 (+0.34), MRK: 58.61 (+1.09), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), GSK: 42.76 (+1.05), BMY: 64.56 (-0.10), SNY: 53.84 (+0.03), NVS: 103.76 (+0.97)
The Pharma Pipeline: Exploring An Underestimated Investment Theme
Manning & Napier - at Seeking Alpha - Tue Jun 30, 2:43PM CDT
Worldwide equity markets have had an impressive showing since emerging from the Great Recession. The run-up in prices has coincided with equities becoming broadly more expensive. Some regions offer more attractive opportunities than others from a...
XBI: 251.38 (-7.56), IBB: 375.89 (-6.95)
40% Return In ~4 Months With Our IP Selected Healthcare Companies Since SA Publication
Innovalpha - Seeking Alpha - Tue Jun 30, 10:48AM CDT
We wanted to know how the " 17 Healthcare Companies To Consider Based On Patent Dynamics And IP/Patent Indexes " performed since SA publication on February 10th 2015, namely JAZZ, SAGE, TNXP, SGYP, ASPX, XNPT, INSM, RNN, NVDQ, ZSPH, ACUR, ICPT, RDHL,...
SGYP: 8.09 (-0.15), INSM: 26.57 (-0.45), RNN: 0.53 (unch), RDHL: 14.73 (-0.68), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), ACUR: 0.81 (+0.07), CORI: 13.93 (+0.13), SPNC: 16.96 (+1.31), SAGE: 68.01 (-4.82), TNXP: 8.05 (-0.03), EBIO: 2.79 (+0.03), HAE: 39.14 (+0.07), JAZZ: 188.80 (-4.22), ICPT: 268.00 (-6.94)
SPDR S&P Biotech ETF Falls 3.34% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Jun 29, 5:30PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $241.30 to a high of $249.80. Yesterday, the shares fell 3.3%, which took the trading range below the 3-day low of $245.92 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
XBI: 251.38 (-7.56)
Biotech Weekly: Top Value Biotech Picks Starting Q3 2015
Daniel Ward - at Seeking Alpha - Mon Jun 29, 10:17AM CDT
OXGN: 1.39 (+0.04), ROKA: 3.09 (+0.02), ECYT: 5.06 (-0.14), BOTA: 2.40 (+0.09), XBI: 251.38 (-7.56), IBB: 375.89 (-6.95), CLDN: 1.25 (unch), NVET: 4.05 (-0.07), BLPH: 3.83 (+0.11), MEIP: 1.64 (+0.07)
5 Stocks Leading XBI Biotech ETF Higher
Zacks Funds - Seeking Alpha - Fri Jun 26, 5:09AM CDT
The biotech corner of the health care space is having a stellar run like last year and still remains a favorite investment destination for investors. This is primarily thanks to strong earnings growth, merger & acquisition frenzy, promising drug...
HRTX: 32.70 (-1.19), XBI: 251.38 (-7.56), RTRX: 31.58 (-1.45), EGRX: 92.27 (-0.57), PRTA: 66.11 (-2.59), EXEL: 5.62 (+0.21)
